{"count":3,"index":{"built_at":"2026-07-27T15:55:06.689206+00:00","public_records":55311,"revision":"d111064517e47a184bf14ceb"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: Insulin in the context of Darmgesundheit"},"results":[{"answer":"The question of insulin in the context of gut health is scientifically relevant, but the available information from the MyBody-X context is limited. Insulin is a key hormone in glucose metabolism, and there is growing evidence of a bidirectional relationship between the gut microbiota and insulin sensitivity. Studies indicate that a disrupted gut barrier (leaky gut) and dysbiosis can contribute to chronic inflammation, which in turn promotes insulin resistance. However, most commercial microbiome tests, such as those offered by MyBody-X, only measure the relative abundance of bacterial species, not functional parameters like insulin levels or inflammatory markers. The evidence for direct causal links between specific bacterial strains and insulin resistance is still largely mechanistic or derived from animal studies. Human studies show moderate associations, but no clinically validated cut-offs exist. Therefore, a standalone microbiome analysis without accompanying blood tests (fasting insulin, HOMA-IR) and medical interpretation is not suitable for diagnosing or managing insulin issues. Caution: Do not start any supplementation or diet based solely on a home test without consulting a physician. Evidence grade: mechanistic/human-moderate.","area":"gesundheit","canonical_id":"gesundheit:canonical-8cae2f2b6b03aa0a2cbef79b","id":"public-f4a6e2266bb78926bc9ebd9c","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Insulin in the context of Darmgesundheit","score":19.14559147,"snippet":"The question of insulin in the context of gut health is scientifically relevant, but the available information from the MyBody-X context is limited. Insulin is a key hormone in glucose metabolism, and there is growing evidence of a bidirectional relationship between the gut microbiota and insulin sensitivity. Studies indicate that a disrupted gut barrier (leaky gut) and dysbiosis can contribute to chronic inflammation, which in turn promotes insulin resistance. However, most commercial microbiome tests, such as those offered by MyBody-X, only measure the relative abundance of bacterial species, not functional parameters like insulin levels or inflammatory markers. The evidence for direct cau","sources":[],"title":"Evidence check: Insulin in the context of Darmgesundheit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-f4a6e2266bb78926bc9ebd9c/evidence-check-insulin-in-the-context-of-darmgesundheit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"SHBG (sex hormone-binding globulin) is primarily produced in the liver and regulated by insulin, thyroid hormones, and estrogens. Low SHBG is a well-established marker for insulin resistance and metabolic syndrome—conditions linked to gut dysbiosis. Observational studies suggest that a high-fiber diet can increase SHBG, possibly mediated by short-chain fatty acids (SCFAs) from gut microbial fermentation. However, direct causal evidence for a gut health–SHBG axis is limited; most data are mechanistic or cross-sectional. DNA tests for SHBG variants (e.g., rs1799941) have negligible clinical utility for gut health, as single SNP effects are small and confounded by lifestyle. In practice, serum SHBG can serve as a metabolic risk indicator but not as a specific gut health biomarker. Safety note: Low SHBG should be evaluated alongside liver function, insulin resistance, and hormone status, not in isolation.","area":"gesundheit","canonical_id":"gesundheit:canonical-8d7823eb69f7942ae8b0a928","id":"public-23935a62b41681b988f237bb","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: SHBG in the context of Darmgesundheit","score":18.75891403,"snippet":"SHBG (sex hormone-binding globulin) is primarily produced in the liver and regulated by insulin, thyroid hormones, and estrogens. Low SHBG is a well-established marker for insulin resistance and metabolic syndrome—conditions linked to gut dysbiosis. Observational studies suggest that a high-fiber diet can increase SHBG, possibly mediated by short-chain fatty acids (SCFAs) from gut microbial fermentation. However, direct causal evidence for a gut health–SHBG axis is limited; most data are mechanistic or cross-sectional. DNA tests for SHBG variants (e.g., rs1799941) have negligible clinical utility for gut health, as single SNP effects are small and confounded by lifestyle. In practice, serum ","sources":[],"title":"Evidence check: SHBG in the context of Darmgesundheit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-23935a62b41681b988f237bb/evidence-check-shbg-in-the-context-of-darmgesundheit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"HbA1c (glycated hemoglobin) is a well-established marker for average blood glucose control over the past 2–3 months, primarily used in diabetes diagnosis and monitoring. There is no direct, clinically validated link between HbA1c and gut health. However, basic research suggests that the gut microbiome can influence insulin sensitivity and glucose metabolism via short-chain fatty acids (e.g., butyrate). Some observational studies show that a high-fiber diet benefits both the gut microbiota and is associated with lower HbA1c levels. Nevertheless, the evidence for a causal pathway from gut health to HbA1c reduction remains weak and mostly mechanistic or observational. In clinical practice, HbA1c is not used as a marker for gut health. Direct-to-consumer tests that present HbA1c in a gut health context often overstate the scientific basis. A healthy, fiber-rich diet is beneficial for both domains, but an isolated HbA1c value without diabetes risk factors tells little about the state of the gut.","area":"gesundheit","canonical_id":"gesundheit:canonical-714ebb33b2c23aa0ace14574","id":"public-5b687dd9d57fd112ef46a5d4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: HbA1c in the context of Darmgesundheit","score":17.97465881,"snippet":"HbA1c (glycated hemoglobin) is a well-established marker for average blood glucose control over the past 2–3 months, primarily used in diabetes diagnosis and monitoring. There is no direct, clinically validated link between HbA1c and gut health. However, basic research suggests that the gut microbiome can influence insulin sensitivity and glucose metabolism via short-chain fatty acids (e.g., butyrate). Some observational studies show that a high-fiber diet benefits both the gut microbiota and is associated with lower HbA1c levels. Nevertheless, the evidence for a causal pathway from gut health to HbA1c reduction remains weak and mostly mechanistic or observational. In clinical practice, HbA1","sources":[],"title":"Evidence check: HbA1c in the context of Darmgesundheit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-5b687dd9d57fd112ef46a5d4/evidence-check-hba1c-in-the-context-of-darmgesundheit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}